Sensipar (cinacalcet), a new drug for dialysis patients

December 2004

Health Canada has just approved Sensipar (cinacalcet), a new drug for dialysis patients.

Chronic kidney disease leads to high serum phosphate...low vitamin D levels...and low serum calcium.

This signals the parathyroid glands to pump out more parathyroid hormone.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Patients benefit when community and hospital pharmacies share info from patient profiles
Men's Health statins might decrease libido or cause erectile dysfunction
Diabetes & Endocrinology Sensipar (cinacalcet), a new drug for dialysis patients
Osteoporosis Is it important to take magnesium along with calcium
Osteoporosis Reps will tout new evidence that Fosamax increases bone density better than Actonel
Dermatology The first biologic treatment for psoriasis, Amevive (Am-uh-veev), is now approved and on the market
Respiratory & Allergy patients aren't aware when their metered-dose inhalers are empty
NATURAL alternatives to Vioxx
Gastroenterology gastric acid-suppressing drugs increasing the risk of pneumonia
Ophthalmology Zymar, another new quinolone ophthalmic antibiotic
Cardiology whether ACE inhibitors are beneficial for patients with STABLE coronary artery disease
Natural Health Products Libracol with HEP 30
Vitamins & Minerals vitamin E supplements might actually INCREASE mortality
whether atenolol should be used for hypertension
Practice End of year is a good time to reflect on trustworthy drug information that is relevant to practice.